Search terms
Results 1 - 10 of 32 - ordered by :
Pages: 1 2 3 4

Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT Tel: +33 1 42 16 55 14; Fax: +33 1 42 16 55 03; Email: ...

European Journal of Heart Failure, Komajda, Michel, Böhm, Michael, Borer, Jeffrey S, Ford, Ian, Robertson, Michele, Manolis, Athanasios J., Tavazzi, Luigi, Swedberg, Karl

Date : 01/07/2014 Item size : 155290 bytes

Device TherapyAuthors Noor Mumin R., Heart Failure Care Group, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, Harefield, Middlesex, UKNational Heart and Lung Institute, ...

European Journal of Heart Failure, Noor, Mumin R., Bowles, Christopher, Banner, Nicholas R.

Date : 01/06/2012 Item size : 158258 bytes

Tel: +44 1782553361, Fax: +44 1782553225, Email: Search for more papers by this author Tan Yu Ting, Department of Cardiovascular Medicine, University of Birmingham, ...

European Journal of Heart Failure, Wenzelburger, Frauke W.G., Tan, Yu Ting, Choudhary, Ferrah J., Lee, Eveline S.P., Leyva, Francisco, Sanderson, John E.

Date : 01/09/2011 Item size : 191271 bytes

Hospitalized heart failure patients with preserved vs. reduced ejection fraction in Dubai, United Arab Emirates: a prospective study Compared with western countries, HF patients in Middle Eastern ...

European Journal of Heart Failure, Saheb Sharif‐Askari, Narjes, Syed Sulaiman, Syed Azhar, Saheb Sharif‐Askari, Fatemeh, Al Sayed Hussain, Ali, Tabatabai, Sadeq, Abdullatif Al‐Mulla, Arif

Date : 01/04/2014 Item size : 166981 bytes

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Infections are relatively rare causes of cardiovascular disease, but bacteria and viruses may affect the pericardium,1 myocardium,24 ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/11/2015 Item size : 253259 bytes

Abstract Aims While mineralocorticoid receptor antagonists (MRAs) have been shown to benefit patients with reduced left ventricular ejection fraction (LVEF), spironolactone did not reduce the primary ...

European Heart Journal, CLINICAL RESEARCH, Scott D. Solomon, Brian Claggett, Eldrin F. Lewis, Akshay Desai, Inder Anand, Nancy K. Sweitzer, Eileen O'Meara, Sanjiv J. Shah, Sonja McKinlay, Jerome L. ...

Date : 01/02/2016

Abstract Objective: Treatment with the β-blocker carvedilol leads to an improvement of outcome and ejection fraction in heart failure. Results: β-Adrenoceptors were downregulated and ...

Cardiovascular Research, Original Article, Michael Böhm, Sylvia Ettelbrück, Markus Flesch, Wiek H van Gilst, Andreas Knorr, Christoph Maack, Yigal M Pinto, Martin Paul, Ard C.H Teisman, Oliver ...

Date : 01/10/1998

Irrespective of the aetiology of heart failure, the net result is vagal attenuation and, over time, progressively pathological augmentation of sympathetic outflow4 and neural and adrenal ...

European Heart Journal, Clinical update, John S. Floras, Piotr Ponikowski

Date : 07/08/2015

Introduction Current evidence suggests that heart rate (HR) may serve both as a modifiable risk factor, and as a disease modifying variable in patients with impaired left ventricular (LV) systolic ...

Heart, BCS Abstracts 2011, S Russell, M Oliver, H Rose, J Davies, H Llewellyn-Griffiths, A Raybould, V Sim, Z R Yousef

Date : 01/06/2011

In a consensus statement of the European Society of Cardiology, the definition of diastolic heart failure is based on signs and symptoms of heart failure, a relatively preserved left ventricular ...

Heart, Editorial, Adriaan A Voors, Richard M de Jong

Date : 01/08/2008